Eucrates Biomedical Acquisition Corp.NASDAQ EUCR Stock Report

Eucrates Biomedical Acquisition Corp. operates as a blank Check company focusing on acquiring, engaging in a share exchange, share reconstruction and amalgamations. The company is headquartered in New York City, New York. The company went IPO on 2020-10-23. The firm is formed for the purpose of acquiring, engaging in a share exchange, share reconstruction and amalgamation with, purchasing all or substantially all of the assets of, entering into contractual arrangements with, or engaging in any other similar business combination with one or more businesses or entities. The firm intends to focus on businesses focusing on the biomedical or healthcare-related industries. The firm is not engaged in any business operations and has generated any revenue.